CEO North America > CEO Life > Food
According to a new study of sugar-sweetened beverage taxes implemented in five U.S. cities, heightened prices of sugary drinks have...
According to early data from a new clinical trial, adolescent and children patients treated with the drug Xolair were less...
On Friday, U.S. pharmaceutical company Bristol Myers Squibb announced its purchase of biopharmaceutical company Karuna Therapeutics for $14 billion. The...
On Tuesday, Coca-Cola recalled 2,000 cases of beverages from the U.S. market. The affected beverages include Sprite, Diet Coke, and...
Snack chip heavyweight Doritos is looking to appeal to a new market with the release of a brand new venture:...
Major drug manufacturer Eli Lilly’s new weight loss drug Zepbound is now available for purchase in U.S. pharmacies, the company...
A new real-world study conducted by Truveta Research has placed Eli Lilly’s blockbuster weight loss drug Mounjaro as more effective...
Major pharmaceutical manufacturer Pfizer is aiming for the weight loss drug market as blockbuster drugs Wegovy and Ozempic continue surging...
While Novo Nordisk’s blockbuster weight loss drug WeGovy has caught repeated flack for its purportedly high price tag, the drug...
Pharmaceutical manufacturer Pfizer released its third quarter financial report on Tuesday, revealing the company experienced a smaller-than-expected adjusted loss in...
Editorials –
stuart.james@ceo-na.com
Advertising –
advertising@ceo-na.com
NEW YORK
110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800
HOUSTON
609 Main St.
Floor 25
Houston, TX
77002
USA
NEW YORK
110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800
HOUSTON
609 Main St.
Floor 25
Houston, TX
77002
USA
CEO North America © 2022 - Sitemap